Tianjin Lisheng PharmaceuticalLtd Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Tianjin Lisheng PharmaceuticalLtd has a total shareholder equity of CN¥5.0B and total debt of CN¥82.9M, which brings its debt-to-equity ratio to 1.7%. Its total assets and total liabilities are CN¥6.0B and CN¥1.0B respectively. Tianjin Lisheng PharmaceuticalLtd's EBIT is CN¥80.1M making its interest coverage ratio -0.8. It has cash and short-term investments of CN¥2.3B.
Belangrijke informatie
1.7%
Verhouding schuld/eigen vermogen
CN¥82.93m
Schuld
| Rente dekkingsratio | -0.8x |
| Contant | CN¥2.27b |
| Aandelen | CN¥5.00b |
| Totaal verplichtingen | CN¥1.01b |
| Totaal activa | CN¥6.02b |
Recente financiële gezondheidsupdates
Analyse van de financiële positie
Kortlopende schulden: 002393's short term assets (CN¥3.0B) exceed its short term liabilities (CN¥746.5M).
Langlopende schulden: 002393's short term assets (CN¥3.0B) exceed its long term liabilities (CN¥267.4M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 002393 has more cash than its total debt.
Schuld verminderen: 002393's debt to equity ratio has increased from 0.6% to 1.7% over the past 5 years.
Schuldendekking: 002393's debt is well covered by operating cash flow (253%).
Rentedekking: 002393 earns more interest than it pays, so coverage of interest payments is not a concern.